Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.38 |
| ▸ | AKR1B10 | O60218 | 5/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | BTK | Q06187 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3310444 | 0.96 | KDM4E (0.39) | ALOX5HCAR2AKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL9402761 | 0.92 | HCAR2 (0.40) | ALOX5HCAR2AKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL3519508 | 0.87 | MAPT (0.38) | ALOX5HCAR2AKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL22367583 | 0.86 | ALOX5 (0.39) | ALOX5HCAR2AKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL9402872 | 0.86 | ATM (0.40) | HCAR2AKR1B10AKR1B1ATMTDP1 | |
| SCHEMBL1068326 | 0.85 | THRB (0.49) | ALOX5HCAR2AKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL9402709 | 0.85 | ATM (0.45) | HCAR2ALDH1A1ATMTDP1 | |
| SCHEMBL17373023 | 0.85 | HCAR2 (0.41) | ALOX5HCAR2AKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL10629493 | 0.85 | HCAR2 (0.41) | ALOX5HCAR2AKR1B10AKR1B1ALDH1A1 | |
| SCHEMBL17287255 | 0.85 | HCAR2 (0.41) | ALOX5HCAR2AKR1B10AKR1B1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118338879-A | Curable composition for dental use | 可乐丽则武齿科株式会社 | 2024-07-12 | — | — | CN | disclosed |
| CN-108333869-B | Photosensitive composition, cured film, method for producing same, and display element, light-emitting element, and light-receiving element | JSR株式会社 | 2023-07-18 | — | — | CN | disclosed |
| CN-111225647-B | Dental composition | 可乐丽则武齿科株式会社 | 2023-02-28 | — | — | CN | disclosed |
| CN-111225647-A | Dental composition | 可乐丽则武齿科株式会社 | 2020-06-02 | — | — | CN | disclosed |
| EP-2228362-B1 | 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE | DOW CORNING TORAY CO LTD (JP) | 2017-06-07 | — | — | EP | disclosed |
| US-8624064-B2 | 4-hydroxyphenylalkylamine derivative | DOW CORNING TORAY COMPANY, LTD. (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20100280188-A1 | 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE | DOW TORAY CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| EP-2228362-A1 | 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE | Dow Corning Toray Co., Ltd. (JP) | 2010-09-15 | — | — | EP | disclosed |
| US-7192986-B2 | Inorganic compound sol modified by organic compound | CATALYSTS & CHEMICALS INDUSTRIES CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-20030193037-A1 | INORGANIC COMPOUND SOL MODIFIED BY ORGANIC COMPOUND | CATALYSTS & CHEMICALS INDUSTRIES CO., LTD. (JP) | 2003-10-16 | — | — | US | disclosed |
| US-5332779-A | Polymerizable silica sol, adamantane derivative for use in the sol and cured resin prepared using the same | KAWASAKI STEEL CORPORATION (JP) | 1994-07-26 | — | — | US | disclosed |
| EP-0460560-A2 | Polymerizable silica sol, adamantane derivative for use in the sol and cured resin prepared using the same | KAWASAKI STEEL CORPORATION (JP) | 1991-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280188-A1 | 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE | HRH3, HRH4, PAH | ALOX5 3747/4885HCAR2 39/4885AKR1B10 787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.